Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

14.26USD
13 Nov 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$14.26
Open
$13.98
Day's High
$14.64
Day's Low
$13.57
Volume
100,874
Avg. Vol
160,590
52-wk High
$34.98
52-wk Low
$12.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 12.51 -0.534
Jun '18 21.34 -0.345
Mar '18 14.18 -0.401
FY 2017 Dec '17 27.07 -0.653
Sep '17 24.14 -0.277
Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 9 18.71 40.30 8.00 21.62
Quarter Ending Mar-19 5 13.93 18.50 6.25 18.50
Year Ending Dec-18 9 68.55 104.00 56.00 66.83
Year Ending Dec-19 9 63.01 104.00 0.00 77.11
Earnings (per share)
Quarter Ending Dec-18 10 -0.48 -0.22 -0.75 -0.24
Quarter Ending Mar-19 5 -0.52 -0.42 -0.73 -0.33
Year Ending Dec-18 9 -1.71 -1.23 -1.91 -1.38
Year Ending Dec-19 10 -2.23 -1.15 -3.23 -2.13
LT Growth Rate (%) 1 -3.30 -3.30 -3.30 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.81 45.61
P/E Low - Last 5 Yrs. -- 85.16 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) 26.31 121.71 5.95
Price to Book (MRQ) 15.16 14.77 4.89
Price to Tangible Book (MRQ) 16.00 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions 76.32 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 387.08 8.08
Sales (TTM) vs TTM 1 Yr. Ago 225.95 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 5.62 5.29 3.07
LT Debt to Equity (MRQ) 0.00 36.70 13.15
Total Debt to Equity (MRQ) 0.00 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -554.68 10.90
Operating Margin (TTM) -209.53 -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.66 6.22
Pre-Tax Margin (TTM) -206.33 -760.61 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.06 6.66
Net Profit Margin (TTM) -206.33 -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.69 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 22,793,236 803,317,434
Net Income/Employee (TTM) -797,026 1,402,790 94,479,245
Receivable Turnover (TTM) 103.37 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) 0.11 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -26.13 -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -81.04 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 99 58
13 Week 32.88 26.41 99 61
26 Week 25.44 15.90 99 74
52 Week 39.97 18.64 99 45
YTD 95.63 71.81 99 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.46%
# of Holders: 197
Total Shares Held: 36,214,208
3 Mo. Net Change: 2,861,129
# New Positions: 4
# Closed Positions: 19
# Increased Positions: 43
# Reduced Positions: 36
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.